Financial Advocates Investment Management - NEUROPACE INC ownership

NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Financial Advocates Investment Management ownership history of NEUROPACE INC
ValueSharesWeighting
Q2 2024$113,400
-14.1%
15,000
+50.0%
0.01%
-12.5%
Q1 2024$132,000
+28.0%
10,0000.0%0.01%
+14.3%
Q4 2023$103,100
+6.0%
10,0000.0%0.01%0.0%
Q3 2023$97,300
+116.7%
10,0000.0%0.01%
+133.3%
Q2 2023$44,900
-3.2%
10,0000.0%0.00%0.0%
Q1 2023$46,400
+211.4%
10,0000.0%0.00%
+200.0%
Q4 2022$14,900
-60.8%
10,0000.0%0.00%
-66.7%
Q3 2022$38,00010,0000.00%
Other shareholders
NEUROPACE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kent Lake Capital LLC 1,144,254$8,650,5603.90%
Soleus Capital Management, L.P. 2,433,168$18,394,7501.62%
Orbimed Advisors 3,406,335$25,751,8930.51%
Nantahala Capital Management 616,823$4,663,1820.27%
Alpine Global Management, LLC 12,923$97,6980.02%
XTX Topco Ltd 24,055$181,8560.02%
Financial Advocates Investment Management 15,000$113,4000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 33,200$250,9920.01%
MILLENNIUM MANAGEMENT LLC 686,037$5,186,4400.00%
ACADIAN ASSET MANAGEMENT LLC 68,918$5200.00%
View complete list of NEUROPACE INC shareholders